Professional
Added to YB: 2024-03-27
Pitch date: 2024-03-27
MOB.ST [bullish]
Moberg Pharma AB (publ)
-60.2%
current return
Author Info
Rogue Funds is a value-oriented hedge fund sharing in-depth analysis. Sign up for the newsletter.
Company Info
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden.
Market Cap
SEK 448.5M
Pitch Price
SEK 22.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.33
P/E
-17.42
EV/Sales
16.30
Sector
Pharmaceuticals
Category
growth
Moberg Pharma: The future of Nail Fungus Cures
MOB.ST: Game-changer toenail fungus treatment MOB-015 (Terclara) has 70%+ cure rate in trials, far outpacing competition. Huge TAM potential: estimates $75M Canada, $1B US, $290M Japan, $40M Korea. Sweden launch underway, 2025 EU/CA rollout. Mgmt proven, $1B+ upside vs $70M mkt cap.
Read full article (7 min)